No information is available on the use of danicopan during breastfeeding. Because danicopan is more than 91% bound to plasma proteins, the amount in milk is likely to be low. However, the manufacturer recommends avoiding breastfeeding during use and for 3 days after the last dose.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Danicopan
CAS Registry Number
1903768-17-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Complement Inactivating Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
